Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Cancer, Papillary 1Polycystic Ovary Syndrome 1Hyperandrogenism 1Anovulation 1Adenocarcinoma, Follicular 1

Interventions

Metformin 7Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2maltodextrin 1bicalutamide 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Ultrasonography 1Topiramate 1Time 1Thioctic Acid 1Sodium Salicylate 1Sex Characteristics 1Physical Examination 1Phlebotomy 1Phenotype 1Ovidrel 1Magnesium 1Lactalbumin 1Inulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hyperandrogenism × Glycoprotein Hormones, alpha Subunit × Clear all
NCT03252223 2021-09-08

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

University of California, San Diego

Phase 4 Completed
33 enrolled

Anovulation, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡